Interim Data Analysis of the ADAPT Trial Using the Modified Intent to Treat (mitt) Population Re-Evaluates Rocapuldencel-T for Clinical Benefit over Standard of Care.
Journal of clinical oncology（2018）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要